Scientific investigators or health professionals who are currently funded by the tobacco industry for any project, or who have been funded by the tobacco industry during the previous four years, or whose named mentors in the case of mentored fellowships are funded by the tobacco industry for any project (currently or during the previous four years) may not apply and will not be eligible for the Colorectal Cancer Alliance research grants. Scientific investigators, health professionals, or named mentors who accept funding from the tobacco industry for any project during the tenure of a Colorectal Cancer Alliance research award must inform the Alliance of such funding, whereupon the Alliance grant will immediately be terminated. Tobacco industry funding includes the receipt of funds from a company that is engaged in or has affiliates engaged in the manufacture of tobacco produced for human use; funds in the name of a tobacco brand, whether or not the brand name is used solely for tobacco products; funds from a body set up by the tobacco industry (e.g., a corporate foundation) or by one or more companies engaged in the manufacture of tobacco products.
The following do not constitute tobacco industry funding for the purposes of this policy:
• Legacies from tobacco industry investments (unless the name of a tobacco company or cigarette brand is associated with them)
• Funding from a trust or foundation established with assets related to the tobacco industry but no longer having any connection with the tobacco industry even though it may bear a name that (for historical reasons) is associated with the tobacco industry.
• Funds from the Master Settlement Agreement of November 23, 1998
For purposes of the Colorectal Cancer Alliance grants, tobacco industry funding is defined as money provided or used for all or any of the costs of the research, including personnel, consumables, equipment, buildings, travel, meetings and conferences, and operating costs for laboratories and offices.
Applicants to the grant program must disclose any additional financial relationships that may impact the integrity of science and results.